Implantech Midface-Submalar Le Fort Implant
510(k) K942420
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK942420 | Date8 Aug 1994 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LZK
- Device Class
- Class II
- Regulation
- 21 CFR Part 878.3550
- Advisory Committee
- General, Plastic Surgery
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 6 Oct 2026
This device is an implant, malar, as defined in the device name and specifications. It is a midface-submalar Le Fort implant intended for use in facial reconstruction or augmentation.
It received FDA 510(k) clearance K942420 on August 8, 1994, under product code LZK and regulation number 878.3550. The device is classified as Class II and is indicated for use in general and plastic surgery.
Other devices from King & Spalding
Questions
AI-generated answers, 6 Oct 2026
What is the IMPLANTECH MIDFACE-SUBMALAR LE FORT IMPLANT used for?
This device is a malar implant designed for midface-submalar Le Fort applications, specifically intended for use in facial reconstruction or augmentation procedures within general and plastic surgery settings, as indicated in its FDA 510(k) clearance documentation.
How was the IMPLANTECH MIDFACE-SUBMALAR LE FORT IMPLANT cleared for market?
The device obtained FDA 510(k) clearance through a traditional submission process, identified as K942420, which was granted on August 8, 1994, after being determined substantially equivalent to a predicate device under product code LZK and regulation 878.3550.
Is the IMPLANTECH MIDFACE-SUBMALAR LE FORT IMPLANT a Class II device?
Yes, the device is classified as Class II by the FDA, as confirmed in its 510(k) clearance documentation, which places it in a moderate-risk category requiring special controls to ensure safety and effectiveness for its intended use in facial reconstruction or augmentation.